IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
about
Prognostic Genetic Signatures in Upper Tract Urothelial CarcinomaUnderstanding the Key to Targeting the IGF Axis in Cancer: A Biomarker AssessmentPredictive models and prognostic factors for upper tract urothelial carcinoma: a comprehensive review of the literatureCSF2 Overexpression Is Associated with STAT5 Phosphorylation and Poor Prognosis in Patients with Urothelial Carcinoma.Identification of Differentially Expressed IGFBP5-Related Genes in Breast Cancer Tumor Tissues Using cDNA Microarray ExperimentsNecdin Overexpression Predicts Poor Prognosis in Patients with Urothelial Carcinomas of the Upper Urinary Tract and Urinary BladderSPOCK1 Overexpression Confers a Poor Prognosis in Urothelial Carcinoma.Serum glucose and hemoglobin A1C levels at cancer diagnosis and disease outcome.Downregulation of RNF128 Predicts Progression and Poor Prognosis in Patients with Urothelial Carcinoma of the Upper Tract and Urinary Bladder.The C-terminus of IGFBP-5 suppresses tumor growth by inhibiting angiogenesisPrognostic factors and predictive tools for upper tract urothelial carcinoma: a systematic review.Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.Overexpression of PTP4A3 is associated with metastasis and unfavorable prognosis in bladder cancer.IGF1R activation and the in vitro antiproliferative efficacy of IGF1R inhibitor are inversely correlated with IGFBP5 expression in bladder cancer.Subcellular localisation of anillin is associated with different survival outcomes in upper urinary tract urothelial carcinoma.Fibulin-3 promotes muscle-invasive bladder cancer.INHBA overexpression indicates poor prognosis in urothelial carcinoma of urinary bladder and upper tract.Upregulation of miR-197 inhibits cell proliferation by directly targeting IGFBP5 in human uterine leiomyoma cells.
P2860
Q26772220-F72A0434-2E99-4555-9C33-8B4BEE426551Q26798408-B402912F-0896-4DB7-B332-98B43FDDFCE8Q28076374-6D1E694F-F68C-42E7-9E97-070ED4EEEB48Q35989342-E8505221-1F45-45AA-861E-DF678DEF65FFQ36401144-739BF12B-C30A-4861-BF24-1711DF29CBB3Q36563911-A181B4C7-AC19-4C61-A545-0AD3751AEE57Q36567906-E78DFDD5-AFA7-46C4-89B3-B77669AFCA6BQ36853961-AC666B07-892C-4947-8B31-1642B851C12FQ37514045-884B0DA3-C06F-4C41-9161-CEAA0DE61DFEQ37529387-3CD904FB-EA1E-442C-B384-DD307AF8CF0AQ38814000-B5B68CDF-ECA7-4DCD-AC35-621D30F46F66Q40798009-55ED20EC-CD57-40E4-B6D4-83F4B029F9AEQ40967704-89F3DADA-C2AC-428B-8884-8116FAD53BA5Q41590246-13ED5889-A74E-4757-B8C3-690BC1FED144Q41620827-98231B5E-565C-4CFF-9512-39206540A14EQ42776532-47D0C2A2-432F-4447-AAAF-DC38310664E1Q43688428-02212350-CAB1-4C5A-8688-B0BB7E705C01Q51629951-F804609D-4AAD-4979-BEF8-59C209D344E3
P2860
IGFBP-5 overexpression as a poor prognostic factor in patients with urothelial carcinomas of upper urinary tracts and urinary bladder.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
IGFBP-5 overexpression as a po ...... ry tracts and urinary bladder.
@en
IGFBP-5 overexpression as a po ...... ry tracts and urinary bladder.
@nl
type
label
IGFBP-5 overexpression as a po ...... ry tracts and urinary bladder.
@en
IGFBP-5 overexpression as a po ...... ry tracts and urinary bladder.
@nl
prefLabel
IGFBP-5 overexpression as a po ...... ry tracts and urinary bladder.
@en
IGFBP-5 overexpression as a po ...... ry tracts and urinary bladder.
@nl
P2093
P2860
P1476
IGFBP-5 overexpression as a po ...... ry tracts and urinary bladder.
@en
P2093
Alex C Liao
Chien-Feng Li
Ching-Yih Lin
Chung-Hsi Hsing
Han-Ping Hsu
Hsuan-Ying Huang
Kun-Hung Shen
Li-Tzon Chen
P2860
P304
P356
10.1136/JCLINPATH-2012-201278
P407
P577
2013-03-28T00:00:00Z